Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 May;22(5):654-665.
doi: 10.1038/s41590-021-00911-7. Epub 2021 Apr 22.

Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity

Affiliations
Clinical Trial

Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity

Sanne E de Jong et al. Nat Immunol. 2021 May.

Abstract

Controlled human infections provide opportunities to study the interaction between the immune system and malaria parasites, which is essential for vaccine development. Here, we compared immune signatures of malaria-naive Europeans and of Africans with lifelong malaria exposure using mass cytometry, RNA sequencing and data integration, before and 5 and 11 days after venous inoculation with Plasmodium falciparum sporozoites. We observed differences in immune cell populations, antigen-specific responses and gene expression profiles between Europeans and Africans and among Africans with differing degrees of immunity. Before inoculation, an activated/differentiated state of both innate and adaptive cells, including elevated CD161+CD4+ T cells and interferon-γ production, predicted Africans capable of controlling parasitemia. After inoculation, the rapidity of the transcriptional response and clusters of CD4+ T cells, plasmacytoid dendritic cells and innate T cells were among the features distinguishing Africans capable of controlling parasitemia from susceptible individuals. These findings can guide the development of a vaccine effective in malaria-endemic regions.

PubMed Disclaimer

Comment in

References

    1. WHO. World Malaria Report 2019, report no. 978-92-4-156572-1 (WHO, 2019).
    1. McCall, M. B. B., Kremsner, P. G. & Mordmuller, B. Correlating efficacy and immunogenicity in malaria vaccine trials. Semin. Immunol. 39, 52–64 (2018). - PubMed - DOI
    1. Duffy, P. E. & Patrick Gorres, J. Malaria vaccines since 2000: progress, priorities, products. NPJ Vaccines 5, 48 (2020). - PubMed - PMC - DOI
    1. Jongo, S. A. et al. Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults. Am. J. Trop. Med. Hyg. 104, 283–293 (2021). - PubMed - DOI
    1. Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47 (2015). - PubMed - PMC - DOI

Publication types

MeSH terms

LinkOut - more resources